Channels

Top 100 Trending New

Categories

Crypto Gaming News Entertainment Music Sports Tech Gambling Bots and mini apps Finance Business Education Lifestyle Health Travel Auto Fashion Jobs Dating Deals and shopping

Stickers

Stickers Emoji Themes Wallpapers

Bots Gifts Tools

Currency

$ USD ₽ RUB € EUR ₴ UAH ₸ KZT ₺ TRY zł PLN ₪ ILS AED AED R$ BRL Rp IDR RM MYR ¥ JPY ₩ KRW CN¥ CNY

Theme

Português (Brasil)

Bahasa Indonesia

Беларуская

Українська

Channels Categories Stickers Bots Gifts Tools

Premium Wiki Glossary Legal

Notifications Settings Log in

Stock market Stats: post #47818 — TG.ME

Stock market Stats@stockinfo333 · 19K subscribers Open in TelegramOpen

ROI | ROE | ROA

t.me/stockinfo333/47818

4

1

September 4, 2026 1.5K 27

More from this channel

[media post] 618·Sep 5

Which battery chemistry will grow where? Just look at the applications and how many verticals the battery industry has. Sodium-ion may be better suited for BESS, but batteries can be made using many different materials, including zinc-based chemistries. First, we must understand the differences and performance ranges. Chemistry determines which battery will be lighter, more durable, safer, and capable of delivering a longer cycle life. Battery chemistry and composition can change significantly every few years. Even China is now exploring different battery types, particularly sodium-ion, to reduce dependence on critical minerals, Africa-linked resources, and concentrated supply chains. Therefore, One must have to study the entire battery-material supply chain. 1.2K·Sep 4 Websites you can use for Investment Research: 1. Stock Screener - Company fundamentals 2. Cafemutual - MF industry updates 3. Value Research - MF analysis & ratings 4. Morningstar - Fund research Advanced 5. Advisorkhoj - MF data & tools 6. RupeeVest - MF analytics (Regular Plan) 7. PMS Bazaar - PMS research 8. Trendlyne - Stock screening & analysis 9. Equitymaster - Equity research Screener 10. IBEF - India industry data 11. IMF - Global macro data 12. TradingView - Charts & technicals 13. UnlistedZone - Unlisted stocks 14. AMFI India - Official MF data 15. StockEdge - Stock analysis 16. MF Central - MF portfolio & transactions 17. PMS AIF World - PMS/AIF data 18. Novel Investor - Valuation research 19. World PE Ratio - Global valuations 20. Macrotrends - 100 years Historical data 21. Economic Outlook - Economic research 22. India Macro Indicators - India macro data 23. Lazy Portfolio ETF - Global ETF research 24. MoSPI - Official statistics 25. PIB - Government updates 26. Fortune India 500 - Company rankings 27. ClearTax - Tax & finance 28. Zerodha Pulse - Market news 29. Trading Economics - Global economic data 1.3K·Sep 4 The numbers explain why peptides are attracting so much attention. 🔹One market estimate places the global peptide therapeutics market at $140.9 billion in 2025 🔹It is projected to reach $294.6 billion by 2033 🔹That implies an 8.7% CAGR 🔹Metabolic disorders accounted for the largest application share in this estimate 👉 The exact market size varies depending on methodology. But the direction is clear: peptides are becoming a significant pharma platform. GLP-1 may be the catalyst, but it is unlikely to be the entire story. 🔹Semaglutide and tirzepatide demonstrated the commercial potential of peptide-based medicines 🔹The pipeline is expanding into dual agonists, multi-agonists and next-generation metabolic therapies 🔹In India, one estimate projects the GLP-1 market to grow from $240.5 million in 2026 to ~$1 billion by 2033 🔹India's anti-obesity drug market has also seen rapid growth alongside GLP-1 adoption 👉 The question is whether this demand creates a lasting manufacturing ecosystem. The peptide value chain is far more layered than a conventional API story. 🔹Amino acids 🔹Protected amino acids & resins 🔹Peptide fragments 🔹Peptide synthesis 🔹Purification & isolation 🔹Peptide API 🔹Sterile fill-finish 🔹Cartridges, syringes & injection devices 👉 Not every company entering peptides will participate across this entire chain. And that difference could determine where the economics ultimately accrue. The real competitive advantage may lie in the difficult steps, not simply in having "peptide capability." 🔹Long peptides require multiple sequential synthesis steps 🔹Small inefficiencies can compound as molecular complexity increases 🔹Purification requires separating the desired molecule from closely related impurities 🔹Commercial manufacturing also requires analytical, regulatory and scale-up expertise 👉 The industry is already facing capacity constraints across peptide APIs, sterile fill-finish, injector devices and glass cartridges. Indian companies are entering the opportunity from very different points in the value chain. 🔹Divi's Laboratories → Building blocks, intermediates and peptide manufacturing integration 🔹Blue Jet Healthcare → Upstream peptide building blocks 🔹Neuland Laboratories → Complex peptide CDMO and commercial-scale synthesis 🔹Laurus Labs → Expanding peptide capabilities within a broader CDMO platform 🔹Sai Life Sciences → Discovery, development and peptide services 👉 The key is to differentiate between announced capability, development capacity and commercial-scale manufacturing. Stock Fundamental in detail @Fundamental3 1.4K·Sep 4

Peptides may be evolving from a specialised drug category into a much broader pharmaceutical manufacturing opportunity. 🔹Applications span diabetes, obesity, oncology, endocrinology and rare diseases 🔹GLP-1 drugs have demonstrated that peptide medicines can address very large patient populations 🔹The next opportunity may lie not only in the drugs, but in the manufacturing ecosystem behind them 👉 A look at the peptide opportunity and India's positioning 1.1K·Sep 4

An open web layer over public Telegram — search, stats and channel reading right in your browser, no account, no install.

Not affiliated with Telegram FZ-LLC; all data comes from public sources.

Catalog

Top channels Categories Countries Search

Content

Stickers Emoji Gifts Themes Wallpapers

Help

Tools Wiki Glossary Blockchain Safety Premium Advertisers Advertising

© 2026 TG.ME · G.Media network· Updated 09/05/2026 · v0.2.0 · cd00242

Privacy Terms DMCA & complaints Report a violation

Similar channels

BROKERAGE REPORTS23.3K subscribers

Wealthcreator40.7K subscribers

Research Reports65.2K subscribers

STOCK AAJ OR KAL [ STOCK MARKET INFO ]19.4K subscribers

𝗟𝗼𝗻𝗴 𝗧𝗲𝗿𝗺 ®™21.9K subscribers

Books - Make India Read17.3K subscribers

𝙎𝙝𝙤𝙧𝙩 𝙏𝙚𝙧𝙢®™31.2K subscribers

MVP-Multibaggers & Value Picks 🦅42.1K subscribers